TELMIZN-CH

Description

TELMIZN-CH contains Telmisartan 40 mg and Chlorthalidone 12.5 mg in tablet form. This combination brings together an angiotensin II receptor blocker (ARB) and a thiazide-like diuretic to support blood pressure control. Telmisartan blocks the action of angiotensin II, while Chlorthalidone helps the kidneys remove excess sodium and water. As a result, the combination can provide complementary antihypertensive effects when prescribed by a healthcare professional.

For related cardiovascular and antihypertensive formulations, explore the Medhexa Pharma product range for pharmaceutical products and business enquiries.

Therapeutic Segment

Cardiovascular Care | Antihypertensive Therapy | Blood Pressure Management | ARBs | Diuretics | Hypertension Management

Uses of TELMIZN-CH

TELMIZN-CH may be prescribed as part of a treatment plan for:

• High blood pressure (hypertension)
• Patients who require combination antihypertensive therapy
• Blood pressure control when a single medicine does not provide adequate control
• Long-term management of elevated blood pressure
• Patients who may benefit from the complementary actions of an ARB and a diuretic

Telmisartan helps relax blood vessels by blocking angiotensin II activity. Meanwhile, Chlorthalidone promotes sodium and water excretion through the kidneys. Therefore, the two ingredients can provide complementary effects for blood pressure management.

Key Benefits of TELMIZN-CH

• Dual-action blood pressure support: Combines Telmisartan and Chlorthalidone through complementary mechanisms.
• Telmisartan 40 mg: Provides ARB activity and helps reduce the effects of angiotensin II.
• Chlorthalidone 12.5 mg: Provides diuretic activity that promotes sodium and water excretion.
• Supports blood pressure control: Helps lower elevated blood pressure when combination therapy is clinically appropriate.
• Convenient combination: Provides two antihypertensive medicines in one tablet.
• Oral tablet formulation: Designed for convenient administration according to the prescribed regimen.

How TELMIZN-CH Works

Telmisartan belongs to the angiotensin II receptor blocker (ARB) class. It selectively blocks angiotensin II from binding to the AT1 receptor. Normally, angiotensin II narrows blood vessels and contributes to increased blood pressure. By blocking this action, telmisartan helps promote blood vessel relaxation and lower vascular resistance.

Chlorthalidone acts as a thiazide-like diuretic. It reduces sodium reabsorption in the kidneys, which increases the excretion of sodium and water. Consequently, it helps reduce fluid volume and supports lower blood pressure.

Together, these two ingredients provide complementary approaches to hypertension management.

Common Side Effects of TELMIZN-CH

Some patients may experience side effects during treatment. Possible effects include:

• Dizziness
• Headache
• Fatigue
• Low blood pressure
• Increased urination
• Diarrhoea
• Nausea
• Muscle cramps
• Changes in electrolyte levels
• Increased thirst

Because Chlorthalidone affects fluid and electrolyte balance, some patients may experience changes in potassium, sodium or magnesium levels. Healthcare professionals may therefore monitor electrolytes during treatment.

Important Safety Information

Use TELMIZN-CH only according to the instructions of a qualified healthcare professional.

Blood Pressure and Dizziness

TELMIZN-CH can lower blood pressure. Therefore, dizziness or light-headedness may occur, particularly when treatment starts or when the body loses too much fluid. If you feel dizzy, take care when standing up and follow your healthcare professional’s advice.

Kidney Function and Fluid Balance

Chlorthalidone can cause fluid loss, which may affect kidney function in susceptible patients. People with kidney disease, heart failure or dehydration may require closer monitoring. Therefore, inform your doctor about any existing kidney condition before starting treatment.

Electrolytes and Potassium

Chlorthalidone can lower potassium, sodium and magnesium levels in some patients. It can also cause other electrolyte disturbances. Consequently, healthcare professionals may check serum electrolytes periodically, especially when risk factors exist.

Uric Acid and Blood Glucose

Chlorthalidone can increase serum uric acid and may worsen hyperuricaemia or trigger gout in susceptible individuals. It can also affect glucose tolerance. Therefore, tell your doctor if you have gout, diabetes or another metabolic condition.

Pregnancy

Telmisartan should not be used during pregnancy because medicines that act directly on the renin-angiotensin system can cause serious fetal injury or death. If pregnancy occurs during treatment, contact your healthcare professional promptly.

Drug Interactions

Tell your healthcare professional about all prescription medicines, over-the-counter medicines and supplements you take. In particular, discuss:

• Other blood pressure medicines
• Potassium supplements or potassium-containing salt substitutes
• Medicines that affect kidney function
• Lithium
• Medicines for diabetes
• Other diuretics
• NSAIDs and other medicines that may affect kidney function

Chlorthalidone can also increase the effect of some antihypertensive medicines. Therefore, your healthcare professional may review your medicines and blood pressure regularly.

For additional information about Chlorthalidone safety, electrolyte monitoring and precautions, refer to the DailyMed Chlorthalidone prescribing information.

Dosage & Administration

Take TELMIZN-CH exactly as prescribed by your healthcare professional.

The appropriate dose depends on the patient’s blood pressure, current treatment, kidney function, electrolyte status and clinical response. A documented Telmisartan 40 mg + Chlorthalidone 12.5 mg formulation uses once-daily oral administration and can be taken with water, with or without food.

Do not increase the dose or change the treatment schedule without medical advice.

If you miss a dose, follow your healthcare professional’s instructions. Do not take an extra tablet unless your healthcare professional specifically advises you to do so.

Storage

• Store TELMIZN-CH in a cool, dry place.
• Protect the tablets from excessive heat and moisture.
• Keep the tablets in their original ALU-ALU packaging until use.
• Keep the blister sealed until administration.
• Protect the product from direct sunlight.
• Keep the medicine out of the sight and reach of children.
• Do not use the tablets after the expiry date printed on the packaging.